Amaero Announces Velo3D Qualification Condition Satisfied for C103 and Ti64

(AUST:3DA),(AUST:3DA.AX),(OTC US:AMROF),(Other OTC:AMROF), ~ Enters into Technical Development Collaboration with Aurburn University ~ MCDONALD, Tenn., July 08, 2025 (GLOBE NEWSWIRE) — Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value C103, refractory alloy, and titanium powders for additive and advanced manufacturing of components utilized by the defense, space, […]

Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference

(NASDAQ:AKBA), CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Nik Grund, Chief Commercial Officer, will participate in a Fireside Chat at the H.C. Wainwright 4th Annual Kidney Virtual Conference on Monday,

Sustainably-Focused WinCup Acquires Paper Cup Manufacturing Capabilities of ConverPack Inc.

ATLANTA, July 08, 2025 (GLOBE NEWSWIRE) — WinCup, Inc., a leading national manufacturer of disposable foodservice products, announced today that it has acquired the paper cup company ConverPack Inc., a global manufacturer of hot and cold paper cups, in a strategic decision that will bolster the company's capability to manufacture more eco-friendly foodservice products. The

RTI and Kinova Partner to Integrate Intelligent Connectivity into Medical Robotics

SUNNYVALE, Calif., July 08, 2025 (GLOBE NEWSWIRE) — Real-Time Innovations (RTI), the software framework company for physical AI systems, today announced its partnership with Kinova, a global leader in professional and medical robotics. This collaboration will provide seamless integration of advanced robotic technologies with data-centric connectivity to simplify and accelerate product lifecycles, reduce program risk,

Vaxart Announces Trading on OTCQX Best Market

(NASDAQ:VXRT),(OTC US:VXRT),(Other OTC:VXRT), SOUTH SAN FRANCISCO, Calif., July 08, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced its common stock has been approved to trade on the OTCQX(R) Best Market. The

Trinity Capital Inc. Provides Details for Second Quarter 2025 Financial Results and Earnings Call

Trinity CapitalInc.(Nasdaq: TRIN) (the “Company”), a leading alternative asset manager, today announced that it will release its second quarter 2025 financial results at 8:00 a.m. ET onWednesday, August 6, 2025. The Company will discuss its financial results on a conference call later that day at12:00 p.m. ET. https://mma.prnewswire.com/media/1248863/Trinity_Capital_v1_Logo.jpg To listen to the call, please dial

Save the Date: King of the Afterparty, Dave Cantin Group, Announces the 2026 NADA Party as a “Celebration for the Industry”

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) — The King of the Afterparty is back and going bigger than ever before. Dave Cantin Group (DCG), a leading mergers and acquisitions advisory company to retail automotive groups and their owners, has set Thursday, February 5th, as the date for its 2026 NADA Afterparty, promising a legendary

Caliber Promotes Greg James to Chief Operating Officer

(NASDAQ:CWD),(NYSE:INN), SCOTTSDALE, Ariz., July 08, 2025 (GLOBE NEWSWIRE) — Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, announced today that Greg James has been promoted to the company's Chief Operating Officer. Greg joined Caliber in October 2024 as COO & Head of Hotel Asset Management and replaced Ignacio Martinez on July 7, 2025.

Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom

(NASDAQ:QNTM),(CNSX:QNTM.CN),(Boerse Frankfurt – Freiverkehr:0K91),(CNSX:QNTM), TORONTO, July 08, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company“), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, Huge Biopharma Australia Pty Ltd., the submission of its patented candidate

HBT Financial, Inc. to Announce Second Quarter 2025 Financial Results on July 21, 2025

(NASDAQ:HBT), BLOOMINGTON, Ill., July 08, 2025 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding company for Heartland Bank and Trust Company, today announced that it will issue its second quarter 2025 financial results before the market opens on Monday, July 21, 2025. A copy of the press release

Scroll to Top